Delivery Order SPE2DB24D2011-SPE2DB25FBRDL
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,568.41 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.29 firm fixed-price delivery order is for the supply of FYCOMPA 2 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of January 16, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price of $1,049.88 and a completion date of June 25, 2025. The contract is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $2,244.47 and a ceiling value of $2,244.47 for the delivery of FYCOMPA 12 MG TABLET 30S. The contract has an ultimate completion date of June 4, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,446.60, for the delivery of the pharmaceutical product FYCOMPA 4 MG TABLET 30S. The contract has an Ultimate Completion Date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,433.14 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This federal contract award to Amerisourcebergen Drug Corp is a $9,774.38 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract provides the pharmaceutical product FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. No set-aside designation is indicated, suggesting this was an open competition contract. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,670.56 and has a completion date of January 17, 2025. It is a Firm Fixed Price contract for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $1,289.36, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order for the supply of FYCOMPA 6 MG TABLET 30S medication, with an ultimate completion date of August 26, 2024. Amerisourcebergen has been awarded multiple contracts and Indefinite Delivery Contracts (IDCs) by various federal agencies, including the DLA and the Department of...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract award, valued at $5,345.44, is for the pharmaceutical product FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. This contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRDLDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,745.22 firm fixed-price delivery order is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since 2002, positioning it as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/25/25 |